Detalles de la búsqueda
1.
The Importance of the Nutritional Factor and the Stage of the Disease in Postoperative Fistula in Patients with Gastric Cancer.
Chirurgia (Bucur)
; 114(2): 259-267, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31060659
2.
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.
Lancet
; 384(9944): 665-73, 2014 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-24933332
3.
Pathological and Molecular Diagnosis of Uveal Melanoma.
Diagnostics (Basel)
; 14(9)2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38732371
4.
Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study.
Lancet Oncol
; 13(3): 300-8, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22277837
5.
The Effects of Oncological Treatment on Redox Balance in Patients with Uveal Melanoma.
Diagnostics (Basel)
; 13(11)2023 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37296758
6.
Delayed Diagnosis of Clostridium difficile Colitis in a 48-Year-Old Woman with a Homozygous Mutation of the UGT1A1 Gene While on Chemotherapy for Colorectal Carcinoma.
Am J Case Rep
; 23: e934361, 2022 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35226656
7.
Underlying Ciliary Body Uveal Melanoma in a Patient with Chronic Lymphocytic Leukemia Presenting for Hyphema.
Diagnostics (Basel)
; 12(6)2022 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35741122
8.
Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO).
Eur J Cancer
; 166: 126-133, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35290913
9.
How specific molecular-targeted agents can make obsolete a 'one size fits all' approach in EGFR-mutated NSCLC treatment (Review).
Exp Ther Med
; 22(4): 1150, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34504595
10.
Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial.
Clin Lung Cancer
; 19(3): 270-279.e3, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29373274
11.
A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus ifosfamide versus gemcitabine plus cisplatin in the treatment of chemo-naive patients with stages III and IV non-small cell lung cancer (NSCLC).
Lung Cancer
; 57(2): 168-74, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17467848
12.
Chemotherapy for elderly patients with advanced cancer: A pilot study in Institute of Oncology Bucharest.
J Transl Int Med
; 3(1): 24-28, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-27847881
13.
Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial.
Lung Cancer
; 37(1): 9-14, 2002 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12057861
Resultados
1 -
13
de 13
1
Próxima >
>>